Peptides Lab
Survodutide
10mg · Lyophilized
≥99.0% HPLC
Fat Loss & Metabolic
Survodutide (BI 456906) — 10mg
GLP-1 / glucagon dual agonist — MASH and obesity research.
Select size
Price
€170
Payment: cryptocurrency only (BTC, ETH, XRP, SOL, USDT, USDC, XMR). Submit the contact form in your cart and we'll reply with the wallet address.
| CAS Number | 2270904-71-7 |
|---|---|
| Molecular Weight | 4889.4 g/mol |
| Purity | ≥99.0% |
| Form | Lyophilized powder |
| Storage | Store at -20°C. Reconstituted: 2–8°C up to 30 days. |
Survodutide is a glucagon/GLP-1 dual receptor agonist developed by Boehringer Ingelheim and Zealand Pharma, in phase III for obesity and phase II for MASH (NASH).
Related research peptides
Peptides Lab
Retatrutide
≥99.2% HPLC
Lyophilized
Fat Loss & Metabolic
Retatrutide (LY3437943)
CAS 2381089-83-2
From
€40
Peptides Lab
Tirzepatide
≥99.1% HPLC
Lyophilized
Fat Loss & Metabolic
Tirzepatide
CAS 2023788-19-2
From
€40
Peptides Lab
Semaglutide
≥99.0% HPLC
Lyophilized
Fat Loss & Metabolic
Semaglutide
CAS 910463-68-2
From
€50
Peptides Lab
Cagrilintide
≥99.0% HPLC
Lyophilized
Fat Loss & Metabolic
Cagrilintide
CAS 1415456-99-3
From
€75